Lead story in FT Alphaville

Pharmaceuticals sector
A look inside the US regulatory loophole that might keep weight-loss jabs affordable

He who understands it, earns it. He who doesn’t, pays it

Top stories in FT Alphaville

FTAV’s further reading

RIP George Wend; Bluesky; safe assets; LinkedIn magic

Bank of England
Is the Bank of England’s inflation survey really tricksy, or are we stupid, or is it both?

Ipsos facto

US equities
Shorting is hot again

Someone alert WallStreetBets

Bloomberg LP
Bloomberg Terminal outage support thread

How then shall we live?

Investing in funds
Taiwan’s huge ETF industry is in an FX pickle

It’s not just a lifer issue

Football
Being bad at football COULD save Man United £726mn

Struggling club risks ending up nearly a yard offside

US financial regulation
SEC commissioner Crenshaw rips the agency’s ‘regulatory Jenga’

‘We are pulling apart our own regulatory foundation — block by block, case by case, and rule by rule’

US economy
Understanding the methodology behind Moody’s US downgrade

It’s just, like, their opinion man

And the FTAV chart quiz winner is . . . 

T+1 delivery

Capital markets
Why credit ratings do (kinda) matter

Woke Marxist Moody’s

UK local government finance
Gauging Reform UK’s pension power

How to move funds and influence people

Promoted Content

Recommended

ExplainerExplainer
About us
How to read FT Alphaville for free
Shopping and gifts
The FT Alphaville swag shop

Most Read

  1. Bloomberg Terminal outage support thread
  2. Being bad at football COULD save Man United £726mn
  3. Shorting is hot again
  4. FTAV’s further reading
  5. SEC commissioner Crenshaw rips the agency’s ‘regulatory Jenga’

More FT Alphaville

Previous page1Next page